By Hanna Vioque ( May 19, 2026, 5:21 PM BST) -- Biopharma business Nxera has accused a rival of infringing its patents covering an engineered version of a protein used extensively in drug discovery research, arguing that the specific variants the biotech used were far too similar to the patented technology. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.